Access to essential medicines for mothers and children: regulatory challenges and gender justice
Aga Natalis, Abdul Jalil · 2026
Read Access to essential medicines for mothers and children: regulatory challenges and gender justice by Aga Natalis, Abdul Jalil (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13276805.txt.
Description
Aga Natalis and Abdul Jalil wrote a 2026 letter to the editor on medicine registration delays as a gender justice issue. A study of nine countries found that on average only seventy-two percent of tracer medicines for mothers, newborns, and children had any registered product. In weaker regulatory systems the share fell as low as twenty-eight percent.
The letter applies the findings to Indonesia, where the drug agency is still being strengthened. Delays can deny pregnant women oxytocin, misoprostol, and magnesium sulfate, standbys against bleeding and eclampsia. Through a feminist legal lens, the authors argue slow, complex registration systematically reproduces inequality for women. They back reforms the study highlights: priority legal pathways for essential medicines, recognition of World Health Organization prequalification, harmonized rules, and digital registration systems.
Catalog record
| CREATOR | Aga Natalis, Abdul Jalil |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6611 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |